To: Thomas M. who wrote (1539274 ) 5/21/2025 11:01:42 AM From: Maple MAGA 3 RecommendationsRecommended By longz Mick Mørmøny Thomas M.
Read Replies (1) | Respond to of 1572779 This summary is provided for our resident cucks, Brumar and Shitshatsu so they get the screening they deserve. Whether a transgender person needs a prostate exam depends on their sex assigned at birth and any medical or surgical transitions they may have undergone: 1. Transgender women (assigned male at birth) Yes , they may still need prostate exams. Even if they have undergone gender-affirming surgery (such as vaginoplasty), the prostate is usually not removed during these procedures. Therefore, transgender women should follow prostate cancer screening guidelines based on age and risk factors (e.g., typically starting around age 50, or earlier if there's a family history or other risk factors). Hormone therapy (estrogen) may shrink the prostate, but does not eliminate the risk of prostate cancer. 2. Transgender men (assigned female at birth) No , they do not have a prostate and therefore do not need prostate exams . Summary: If a person has a prostate , regardless of gender identity, they may need prostate cancer screening. Always best to consult with a knowledgeable healthcare provider who understands transgender health to get personalized advice. For Transgender Women (assigned male at birth): On Estrogen + Anti-androgens: Estrogen and androgen blockers reduce testosterone levels, which are a major driver of prostate growth and prostate cancer. Studies show that transgender women on long-term hormone therapy tend to have a significantly lower risk of prostate cancer compared to cisgender men. One Dutch study (2020) found that transgender women had a 5x lower incidence of prostate cancer , likely due to testosterone suppression. Important Caveats: The prostate is rarely removed during gender-affirming surgery. Although estrogen lowers risk, prostate cancer can still occur , especially in older trans women or those not on hormones for long. Screening Challenges: Symptoms may be masked or misattributed. Rectal exams and PSA (Prostate-Specific Antigen) tests are still relevant but may be interpreted differently due to hormone effects. Key Takeaway: Yes , estrogen hormone therapy reduces the risk of prostate cancer. No , it does not eliminate the risk—trans women should still be screened appropriately if they retain their prostate.